Alexion Pharmaceuticals
Fang Liu is a seasoned professional with extensive experience in clinical program management and leadership within the pharmaceutical industry. Currently serving as the Director of Portfolio & Program Management at Alexion Pharmaceuticals, Inc. since April 2019, Fang has previously held roles such as Clinical Programs Leadership at Biogen and Global Clinical Program Lead at Shire. With a strong background in clinical operations developed through positions at Novartis Vaccines and Diagnostics and Takeda Pharmaceuticals, Fang's expertise is complemented by academic credentials, including a Ph.D. in Biochemistry from Boston University and a B.S. in Biology from Fudan University.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.